H Vaverková
- Surgery
- Endocrinology, Diabetes and Metabolism top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Epidemiology
- Cancer Research
- Co-authors
- David KarásekĽubica CibičkováLuděk SlavíkKateřina LangováMichel FarnierLuc MissaultPhilippe BrudiMaurizio Averna
- Topics
- Lipoproteins and Cardiovascular Health (39 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers)Adipokines, Inflammation, and Metabolic Diseases (15 papers)
- Partner nations
- CzechiaEstoniaUnited States
In The Last Decade
H Vaverková
66 papers receiving 501 citations
Peers
Comparison fields: 5 of 73
- Surgery 226
- Endocrinology, Diabetes and Metabolism 200
- Cardiology and Cardiovascular Medicine 170
- Epidemiology 151
- Cancer Research 76
Countries citing papers authored by H Vaverková
This map shows the geographic impact of H Vaverková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Vaverková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Vaverková more than expected).
Fields of papers citing papers by H Vaverková
This network shows the impact of papers produced by H Vaverková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Vaverková. The network helps show where H Vaverková may publish in the future.
Co-authorship network of co-authors of H Vaverková
This figure shows the co-authorship network connecting the top 25 collaborators of H Vaverková. A scholar is included among the top collaborators of H Vaverková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Vaverková. H Vaverková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 21 | |
| 4 | [PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated?Czech atherosclerosis society statement]. | 1 |
| 5 | 4 | |
| 6 | Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011 | 0 |
| 7 | 8 | |
| 8 | Relationship between serum adipocyte fatty acid-binding protein and endothelial/hemostatic markers in dyslipidemic subjects. | 3 |
| 9 | Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects. | 5 |
| 10 | Smíšená dyslipidemie - současné možnosti léčby | 1 |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 15 | |
| 14 | 19 | |
| 15 | 2 | |
| 16 | 6 | |
| 17 | 22 | |
| 18 | 16 | |
| 19 | Endoteliální dysfunkce, možnosti její detekce a využití v klinické praxi | 2 |
| 20 | 8 |
About H Vaverková
H Vaverková is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 71 papers that have together received 526 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (39 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers) and Adipokines, Inflammation, and Metabolic Diseases (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (200 citations), Cardiology and Cardiovascular Medicine (170 citations) and Nephrology (38 citations). H Vaverková has collaborated with scholars based in Czechia, Estonia and United States. Frequent co-authors include David Karásek, Ľubica Cibičková, Luděk Slavík, Kateřina Langová, Michel Farnier, Luc Missault, Philippe Brudi, Maurizio Averna, Margus Viigimaa and Jiří Fröhlich. Their work appears in journals such as Clinica Chimica Acta, Atherosclerosis and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.